Steve Warner Email & Phone Number
@bostonbiomedical.com
LinkedIn matched
Who is Steve Warner? Overview
A concise factual answer block for searchers comparing this professional profile.
Steve Warner is listed as Senior Vice President, Head of Translational Research & Medicine - Oncology at Sumitomo Pharma America, based in Salt Lake City, Utah, United States. AeroLeads shows a work email signal at bostonbiomedical.com and a matched LinkedIn profile for Steve Warner.
Steve Warner previously worked as Senior Vice President, Head of Translational Research & Medicine at Sumitomo Pharma America and Senior Vice President, Head of US Research at Sumitomo Pharma Oncology. Steve Warner holds Ph.D., Pharmaceutical Sciences from University Of Arizona.
Email format at Sumitomo Pharma America
This section adds company-level context without repeating Steve Warner's masked contact details.
AeroLeads found 1 current-domain work email signal for Steve Warner. Compare company email patterns before reaching out.
About Steve Warner
Steven Warner, PhD, specializes in small molecule drug discovery, new screening platforms in drug discovery, and translational research focusing on cancer therapeutics. He is an expert in the discovery of novel cancer agents and has played integral roles in moving multiple compounds into clinical trials. Dr. Warner has a broad background in molecular and cell biology that comes from more than two decades of drug discovery and development in both academic and pharmaceutical industry settings. At the University of Arizona, he worked on the validation of novel drug targets for the treatment of pancreatic cancer and discovered first-in-class compounds targeting the Aurora kinases. At the Translational Genomics Research Institute (TGen), Dr. Warner led an effort to screen genome-wide siRNA libraries and large chemical libraries in order to identify molecular targets and therapeutic agents synthetic lethal with DPC4/SMAD4 deletions in pancreatic cancer. He also worked on validating TPX2 as a therapeutic target in pancreatic cancer and identified small molecule inhibitors of this pathway. In 2007, Dr. Warner joined SuperGen Inc. where he led a team of scientists focusing on studies ranging from initial compound library screens to proof-of-concept studies in animal models. Dr. Warner worked at the Center for Investigational Therapeutics at the Huntsman Cancer Institute as Senior Manager, Drug Discovery. His work at the Huntsman Cancer Institute led to the foundational technology for Tolero Pharmaceuticals, which he co-founded in 2011. Tolero was acquired by Sumitomo Dainippon Pharma in 2017 where Dr. Warner has remained as the Head of Research. Together in these capacities, he has led or integrally participated in drug discovery projects that have produced ten first-in-human clinical compounds and has published dozens of peer-reviewed publications and patents from multiple drug discovery projects.Specialties: Cancer Drug Discovery and DevelopmentTranslational Research Focusing on Cancer Therapeutics
Listed skills include Drug Discovery, Cancer, Genomics, Pharmaceutical Industry, and 17 others.
Steve Warner's current company
Company context helps verify the profile and gives searchers a useful next step.
Steve Warner work experience
A career timeline built from the work history available for this profile.
Senior Vice President, Head Of Us Research
Vice President, Head Of Discovery
Co-Founder And Vice President Of Drug Discovery And Development
Led the scientific strategies and activities at Tolero Pharmaceuticals.
Senior Manager, Drug Discovery
Led and worked with a team that discovered and developed preclinical candidate molecules for five molecular targets. Three of these five programs have now been partnered with pharmaceutical companies.
Manager, Discovery Biology
Led a team of in vitro and in vivo biologists working on multiple drug discovery projects ranging from initial compound library screens to proof of concept work in animals.
Postdoctoral Fellow
High throughput screening of siRNA and small molecule libraries to identify synthetic lethal combinations with DPC4/SMAD4 deletions in pancreatic cancer.Validation of TPX2 as a molecular target in pancreatic cancer and targeting this pathway with therapeutic agents.
Steve Warner education
Ph.D., Pharmaceutical Sciences
B.S., Biology
Frequently asked questions about Steve Warner
Quick answers generated from the profile data available on this page.
What company does Steve Warner work for?
Steve Warner works for Sumitomo Pharma America.
What is Steve Warner's role at Sumitomo Pharma America?
Steve Warner is listed as Senior Vice President, Head of Translational Research & Medicine - Oncology at Sumitomo Pharma America.
What is Steve Warner's email address?
AeroLeads has found 1 work email signal at @bostonbiomedical.com for Steve Warner at Sumitomo Pharma America.
Where is Steve Warner based?
Steve Warner is based in Salt Lake City, Utah, United States while working with Sumitomo Pharma America.
What companies has Steve Warner worked for?
Steve Warner has worked for Sumitomo Pharma America, Sumitomo Pharma Oncology, Tolero Pharmaceuticals, Inc., Huntsman Cancer Institute, and Supergen.
How can I contact Steve Warner?
You can use AeroLeads to view verified contact signals for Steve Warner at Sumitomo Pharma America, including work email, phone, and LinkedIn data when available.
What schools did Steve Warner attend?
Steve Warner holds Ph.D., Pharmaceutical Sciences from University Of Arizona.
What skills is Steve Warner known for?
Steve Warner is listed with skills including Drug Discovery, Cancer, Genomics, Pharmaceutical Industry, Cell Biology, In Vitro, Translational Research, and Clinical Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial